Table A2.
Detailed overview of each deprescribed medication, reason for deprescribing, and whether the deprescribing status was sustained at 30 days and 365+ days post inclusion in the control group.
| Patient, Sex, Age | Deprescribed Medication (ATC Code) |
Reason for Deprescribing | Discontinued or Reduced Dose |
Sustained Deprescribing |
|
|---|---|---|---|---|---|
| 30 Days |
365 + Days |
||||
| 22, F, 69 | Venlafaxine (N06AX16) Folic acid (B03BB01) |
Side effect ** Prescribed beyond the recommended duration |
D D |
+ + |
+ + |
| 23, F, 84 | Alogliptin (A10BH04) | Duplicate drug class | D | + | † |
| 24, M, 82 | Colchicin (M04AC01) | Long-term use ** | D | + | + |
| 25, F, 61 | Insulin aspart (A10AB05) | Duplicate drug class | D | + | + |
D, discontinued; R, reduced dose; F, female; m, Male. ** Danish clinical guidelines and/or clinical observations; + sustained deprescribing.